Source Feed: The Globe and Mail
Author: Nicole Ireland
Publication Date: August 17, 2026 - 12:58
Stay informed
Health Canada approves drug for hot flashes in breast cancer patients
August 17, 2026
Elinzanetant, also known by the brand name Lynkuet, has shown effectiveness in reducing hot flashes and night sweats in breast cancer patients whose estrogen-suppressing treatment has put them into menopause.
Unpublished Newswire
The City of Calgary's contracts come as the Calgary Stampede evaluates bids to study the possibility of multi-purposing GMC Stadium to allow for field sports.
August 26, 2026 - 22:30 | Adam MacVicar | Global News - Canada
The first conviction under FWRISA has some experts saying there is a larger pattern of employers abusing foreign workers programs.
August 26, 2026 - 21:44 | Grace Miller | Global News - Canada
August 26, 2026 - 21:15 | Matthew Frank | The Globe and Mail
Comments
Be the first to comment